Methods are provided for treating arrhythmia in a manner that minimizes undesirable side effects, comprising administration of a therapeutically effective minimal dose of an A.sub.1 adenosine receptor agonist with a therapeutically effective minimal dose of a beta blocker, calcium channel blocker, or a cardiac glycoside.

 
Web www.patentalert.com

< Beta-secretase substrates and uses thereof

> Bicyclic heterocycles, processes for their preparation and their use as herbicides and pharmaceutical agents
~ 00492